NEFIDYL®
Enteric Toxic Reduction Technology for Kidney Patients
Nefidyl®, a new hope for patients with kidney problems, is a new generation probiotic that is used to improve the quality of life of people living with kidney health and kidney problems.
Unfortunately ; Chronic Renal Failure is increasing day by day. Two main factors are diabetes and hypertension, and millions of people are at risk. People who have kidney problems are left alone with dialysis or transplantation options.
Worldwide, the number of patients with Chronic Renal Failure is increasing rapidly, and in the next decade, it is considered a major public health problem, posing a threat to reaching out to epidemic dimensions.
In normal body work, nitrogenous wastes such as urea, creatine and uric acid are excreted from the body through the kidneys.
These waste materials cannot be removed from our bodies when they cannot perform renal function.
Recent studies have shown that; 4 to 5% of the adult population live in Stage 3 and Stage 4 in renal failure.
* CKD Stage 3 = Creatinine Clearance 60-30 cc / min.
* CKD stage 4 = creatinine clearance 30-15 cc / min.
Nefidyl® is a probiotic specifically designed for patients with renal insufficiency. It is a hope for dialysis and transplantation for early-stage renal disease. For dialysis patients, it is a product that should be used to become a healthier individual that increases the quality of life.
The bacteria contained in Nefidyl® reach the intestine through the enteric container and dissolve therein. These bacteria are urea, uric acid, creatinine and so on. use nitrogenous wastes. They are then discharged from the body with feces. This process is called Enteric Toxin Reduction and helps to reduce the load on the kidneys and protect the kidney function.
Nefidyl® is specially formulated with gram-positive bacteria available in food.